Elligo Health Research, a healthcare-enabling research organization, is launching their System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.
Elligo’s SOAR model expands patient access to reach diverse patient populations that typically don’t have access to clinical research as a care option. The solution drives efficiency by enabling direct data from source to submission and full remote site access, empowering patients, physicians, and sponsors to conduct more trials efficiently and faster in traditional and decentralized models.
“We are extremely excited to launch our tech-enabled solution created to keep the patient and the physician at the heart of its design, while providing sponsors transparency,” said John Potthoff, PhD, CEO of Elligo. “Our goal has always been to provide all patients with access to research as a healthcare option, which is important now more than ever as we navigate the future of clinical research.”
SOAR aims to adhere to regulations and improves data quality while decreasing resource requirements and costs associated with clinical research. Paired with technology-enabled services and personnel, this model accelerates research without compromising quality and integrity. This provides a pathway to either use traditional research sites, DCTs, or hybrid trials, seamlessly moving between options without causing disruption for any stakeholders. This modernizes clinical research for a new paradigm in a new age of clinical research.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.